Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.603ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.603ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.70EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.70ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.70ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.70EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.606EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.606EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.606ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.606ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.606EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.606EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.606ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.606ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.383EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.383EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.383ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.383ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.383EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.383EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.383ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.383ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.95 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.95 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.95 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.95 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.95 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.95 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.95 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.95 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.189EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.189ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.189ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.189EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.189EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.189ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.189ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used